PR Newswire EDINBURGH, Scotland and LONDON, Nov. 11, 2024 – Complete 3-year clinical data from the MATCH Phase 2 study demonstrate long-term efficacy and safety with autologous, non-engineered macrophages in patients with advanced liver ...
PR Newswire SEOUL, South Korea, Nov. 7, 2024 The biosensor detects symmetric dimethylarginine in urine, offering earlier detection of kidney dysfunction compared to creatinine SEOUL, South Korea, Nov. 7, 2024 /PRNewswire/ -- ...
PR Newswire KENNEDY SPACE CENTER, Fla., Nov. 1, 2024 The SpaceX CRS-31 mission to the ISS for NASA includes studies on in-space manufacturing, cardiac health, and a method to repair spacecraft damaged by debris KENNEDY SPACE CENTER, ...
PR Newswire SAN ANTONIO, Nov. 1, 2024 U.S. Army Medical Research and Development Command Funds FORCE Study to Evaluate Advanced Hemorrhage Control Technology on the Battlefield - Prytime Medical SAN ANTONIO, Nov. 1, 2024 /PRNewswire/ -- ...
PR Newswire MILAN, Nov. 1, 2024 MILAN, Nov. 1, 2024 /PRNewswire/ -- Diadem SpA, in partnership with researchers from the University of Texas Medical Branch, led by Prof. Rakez Kayed from the Mitchell Center for Neurodegenerative Disorders, ...
PR Newswire CONCORD, Calif., Oct. 29, 2024 CONCORD, Calif., Oct. 29, 2024 /PRNewswire/ -- In an exciting development, Center for Social Dynamics (CSD) has been granted approval for an Institutional Review Board (IRB) to conduct research ...
PR Newswire BOSTON, Oct. 24, 2024 As over 2.5 million visits to the emergency department occur annually in the US for TBI, innovative software is discovering previously undiagnosed progressive symptoms BOSTON, Oct. 24, 2024 /PRNewswire/ ...
PR Newswire FRESNO, Calif., Oct. 24, 2024 2 daily handfuls of pistachios may help protect the eyes from blue light damage and could reduce the risk of age-related vision problems. FRESNO, Calif., Oct. 24, 2024 /PRNewswire/ -- Could 2 ...
PR Newswire WASHINGTON, Oct. 23, 2024 WASHINGTON, Oct. 23, 2024 /PRNewswire/ -- Tuberculosis rates have rebounded after decades of decline thanks to open borders. Rates of infection of the potentially deadly disease began to steadily ...
PR Newswire NEW YORK, Oct. 22, 2024 NEW YORK, Oct. 22, 2024 /PRNewswire/ -- Extend Fertility, a leading fertility clinic in New York and a pioneer in making egg freezing more affordable and accessible, today announced the results of an ...
Imagine charging your phone without a plug—just by moving your body! With innovative technology harnessing the power of motion, each step or gesture generates energy that fuels your device. It's the ultimate way to stay connected while staying ...
Women get less restorative sleep than men because of their lifestyles and caregiving roles. They sleep less and wake up more often. A new study published in the journal Scientific Reports experimented on mice to find the sleep ...
Neonatal hypoxic-ischemic encephalopathy (HIE) is a brain dysfunction condition in newborns due to inadequate oxygen and blow flow to the brain at term or near birth. It affects 1-2 per 1,000 live births in high-resource countries . HIE is the reason for the deaths of over half a million worldwide each year. Therapeutic hypothermia is the standard treatment for moderate to severe HIE. Many infants treated with hypothermia still experience significant motor, cognitive and behavioral disabilities by school age. In low-income regions therapeutic hypothermia is unavailable and the need for new, accessible treatment is urgent. Therapies for Neuroprotection in Neonatal Hypoxic-Ischemic Encephalopathy A recent review has highlighted cutting-edge approaches to protect the newborn brain. These therapies target complex mechanisms of HIE related brain injury including inflammation, oxidative stress and cell death. Anti-excitotoxic agents like magnesium sulfate and xenon can limit brain damage caused by excessive glutamate release. Antioxidants such as allopurinol and melatonin reduce oxidative stress and improve the condition when combined with other therapies. Multi-mechanism agents like cannabidiol and caffeine promote neuroregeneration while addressing multiple pathways of injury. Stem cell therapy can repair brain damage through regenerative mechanisms. Challenges in Implementing Alternative Therapies Preclinical studies show promising results but implementing these therapies into effective clinical treatments for neonatal HIE presents many difficulties: Identifying the ideal time for administering neuroprotective therapies with the timing of hypoxic-ischemic events is important. The timing, severity and location of brain injury in hypoxic-ischemic encephalopathy can vary significantly between individuals. Need for reliable biomarkers that can assess the severity and progression of brain injury in real time, which can lead to more personalized and accurate treatment. Safe and effective delivery of these therapies to infants poses a significant challenge. Advancements in personalized medicine and combined therapies can improve treating newborns with HIE. The development of affordable and accessible treatments can revolutionize care for this life-altering condition and give hope to families. Reference: Neuroprotection for neonatal hypoxic-ischemic encephalopathy: a review of novel therapies evaluated in clinical studies- (https:...
A new study has revealed that young adults at risk of psychosis exhibit reduced brain connectivity, a deficiency that seems to be exacerbated by cannabis use. This finding opens the door for developing treatments for psychosis that address symptoms ...
Vagus nerve stimulation may help alleviate the symptoms of inflammatory bowel disease (IBD), suggests a new study. According to a team of researchers at Duke University School of Medicine, targeting the nervous system could help reduce the ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers